You are here

  • Zarin D, Tse T. The effect of funding source on outcome reporting among drug trials [Letter]. Ann Intern Med. 2011 Jan 18;154(2):137-8; author reply 138. doi: 10.7326/0003-4819-154-2-201101180-00020.
  • Wood FB, Siegel ER, Dutcher GA, Ruffin A, Logan RA. The National Library of Medicine's Native American Outreach Portfolio: A Descriptive Overview J Med Libr Assoc. 2005 Oct;93(4 Suppl):S21-34
  • Ross JS, Mocanu M, Lampropulos JF, Tse T, Krumholz HM. Time to publication among completed clinical trials. JAMA Intern Med. 2013 May 13;173(9):825-8. doi: 10.1001/jamainternmed.2013.136.
  • Zarin DA, Tse T, Ide NC. Trial Registration at ClinicalTrials.gov between May and October 2005 N Engl J Med. 2005 Dec 29;353(26):2779-87
  • Zarin D, Tse T. Trust but verify: trial registration and determining fidelity to the protocol [Letter]. Ann Intern Med. 2013 Jul 2;159(1):65-7. doi: 10.7326/0003-4819-159-1-201307020-00011.
  • Williams RJ. Tutorial: ClinicalTrials.gov: Registration and Results Submission Requirements
  • Zarin DA, Tse T. Unambiguous identification of obesity trials [Letter]. N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018.
  • Tse T, Williams RJ, Zarin DA. Update on Registration of Clinical Trials in ClinicalTrials.gov. Chest. 2009 Jul;136(1):304-5. doi: 10.1378/chest.09-1219.
  • Beaudoin DE, Longo N, Logan RA, Jones JP, Mitchell JA. Using information prescriptions to refer patients with metabolic conditions to the Genetics Home Reference website. J Med Libr Assoc. 2011 Jan;99(1):70-6. doi: 10.3163/1536-5050.99.1.012.

Pages